Watch ALMR. Know when insiders buy.
One email the day a filing lands. Free.
ALMR
Alamar Biosciences, Inc.
26.30
+1.02 +4.03%
USD · close Oct 19
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
35
FLAG · insiders 25, shorts 45
Insiders, 90 days
−$4.8M
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 19.09 – 38.13
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $29.4M | — | 60.2% | −$13.5M | −$13.2M | — | -0.22 | −$11.3M | $3.6M | −$15M | Aug 11 |
| Q1 2026 · Mar 31 | $26M | — | 55.5% | −$12.3M | −$21.3M | — | -1.74 | −$20.3M | $600K | −$20.9M | Aug 11 |
| Q2 2025 · Jun 30 | $16.2M | — | 53.1% | −$7.9M | −$7M | — | -0.62 | −$11.9M | $753K | −$12.6M | Aug 11 |
| Q1 2025 · Mar 31 | $13.1M | — | 48.8% | −$8.6M | −$7.7M | — | -0.68 | −$13.1M | $554K | −$13.6M | Aug 11 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Alamar Biosciences, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.